Forest Laboratories, Inc. (FRX)

Analysts 0
Positive
n/a
Median target n/a


    • 06/18/14
      Morgan Stanley
      overweight
    • 06/06/14
      Zacks
      neutral
      $99
    • 05/27/14
      FBR Capital Markets
      market perform
      $88
    • 01/27/14
      Leerink Swann
      outperform
      $84
    • 01/22/14
      Susquehanna
      neutral
      $75
    • 01/22/14
      Barclays
      equal weight
      $74
    • 01/17/14
      Credit Suisse
      outperform
      $85
    • 01/14/14
      Argus
      buy
      $77
    • 01/09/14
      Buckingham Research
      buy
    • 01/09/14
      CRT Capital
      buy
      $78
    • 12/19/13
      Piper Jaffray
      overweight
      $49
    • 12/11/13
      UBS
      neutral
      $93
    • 12/03/13
      SunTrust
      buy
      $72
    • 12/03/13
      Goldman Sachs
      $65
    • 11/22/13
      Mizuho
      buy
      $59
    • 10/25/13
      BMO Capital Markets
      market perform
      $33
    • Positive
      Median: -

    Best rated in Drug Manufacturers - Other last 7 days

    more

    Users who viewed FRX also viewed

    more

    Best rated stocks last 7 days

    more

    Most rated stocks last 72 hrs

    more